FRANKFURT (Reuters) - German drugmaker Bayer requested European approval for a contraceptive skin patch as it seeks to broaden its birth-control business and challenge Johnson & Johnson's Evra patch. The hormonal contraceptive, to be produced for Bayer by Swiss company Acino, was shown to be effective with a good safety profile in clinical trials involving 4,200 women, Bayer said on Thursday. It added that detailed results will be presented at the FIGO World Congress of Gynecology and Obstetrics in Rome in October. ...
Continue reading...
No comments:
Post a Comment